Free Trial
OTCMKTS:EMMA

Emmaus Life Sciences (EMMA) Stock Price, News & Analysis

Emmaus Life Sciences logo
$0.01 0.00 (-0.72%)
As of 09:55 AM Eastern

About Emmaus Life Sciences Stock (OTCMKTS:EMMA)

Key Stats

Today's Range
$0.0138
$0.0138
50-Day Range
$0.0120
$0.0199
52-Week Range
$0.00
$0.10
Volume
4,000 shs
Average Volume
41,969 shs
Market Capitalization
$881.41 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive EMMA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Emmaus Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

EMMA Stock News Headlines

Trump’s Exec Order #14154 could be a “Millionaire-Maker”
Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape.
Emmaus Life Sciences Inc
See More Headlines

EMMA Stock Analysis - Frequently Asked Questions

Emmaus Life Sciences' stock was trading at $0.0085 at the start of the year. Since then, EMMA stock has increased by 62.4% and is now trading at $0.0138.

Emmaus Life Sciences, Inc. (OTCMKTS:EMMA) posted its quarterly earnings data on Thursday, May, 15th. The company reported ($0.04) earnings per share (EPS) for the quarter.

Shares of EMMA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Emmaus Life Sciences investors own include Humanigen (HGEN), Fulcrum Therapeutics (FULC), Sorrento Therapeutics (SRNE), Acasti Pharma (ACST), Actinium Pharmaceuticals (ATNM) and Entasis Therapeutics (ETTX).

Company Calendar

Last Earnings
5/15/2025
Today
7/07/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:EMMA
Employees
60
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$6.45 million
Pretax Margin
-26.55%

Debt

Sales & Book Value

Annual Sales
$16.65 million
Price / Cash Flow
N/A
Book Value
($0.88) per share
Price / Book
-0.02

Miscellaneous

Free Float
41,513,000
Market Cap
$881.41 thousand
Optionable
Not Optionable
Beta
7.55
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (OTCMKTS:EMMA) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners